Tilray Brands Inc (TLRY) is not a strong buy for a beginner investor with a long-term strategy at this time. While the company has shown growth in revenue and improvements in gross margin, its significant net income decline, negative EPS, and mixed analyst ratings suggest caution. The technical indicators and options data do not provide a compelling entry point, and there are no strong positive catalysts or trading signals to support immediate action.
The MACD is positive but contracting, indicating a lack of momentum. RSI is neutral at 54.181, and moving averages are converging, showing no clear trend. The stock is trading near its pivot level of 6.563, with resistance at 7.021 and support at 6.104.

Revenue increased by 11.28% YoY in Q3 fiscal 2026, with strong growth in the beverage segment. Analysts note potential for regulatory changes and improving international operations.
Net income dropped by 96.63% YoY, and EPS fell by 97.24%. Analysts have lowered price targets citing challenges in the core cannabis business, uncertainty over hemp restrictions, and higher aluminum costs impacting the beverage segment.
In Q3 fiscal 2026, revenue increased to $206.73 million (up 11.28% YoY), gross margin improved to 24.11% (up 55.35% YoY), but net income dropped to -$26.57 million (down 96.63% YoY), and EPS fell to -$0.24 (down 97.24% YoY).
Analyst sentiment is mixed. Roth Capital upgraded the stock to Buy with a $10 price target, citing improved international operations and beverage growth. However, Canaccord, Alliance Global, and TD Cowen have lowered price targets, citing challenges in core cannabis operations, regulatory uncertainty, and rising costs.